First Page | Document Content | |
---|---|---|
![]() Date: 2014-01-06 12:09:42Biotechnology Cell biology Stem cell Myocardial infarction SDF3 SDF-4 Biology Stromal cell-derived factor SDF-1 | Add to Reading List |
![]() | Microsoft Word - LOMdocxDocID: 1gAUW - View Document |
![]() | Rivaroxaban, a factor Xa inhibitor, improves neovascularization in the ischemic hindlimb of streptozotocin-induced diabetic miceDocID: 1fSQN - View Document |
![]() | Article Discovery and Characterization of an Endogenous CXCR4 Antagonist Graphical AbstractDocID: 1fwra - View Document |
![]() | Turning Spiegelmers into Drugs NOXXON Pharma is a biopharmaceutical company pioneering the development of a new class of proprietary therapeutics called Spiegelmers*, the chemically synthesized, immunologically passive aDocID: 1a5Tb - View Document |
![]() | analysis from the makers of andDocID: 19mhM - View Document |